Cognitive Remediation Journal 2020, 9(1):1-8 | DOI: 10.5507/crj.2020.001

Affective and personality disorders in Parkinson's disease premotor phase. Pilot study.

Samushiya M.A.1, Ragimova A.A.1, Smolentseva I.G.2, Maksimenko M.Yu.3, Ivannikova E.I.1
1 Central State Medical Academy of Department of Presidential Affairs, Moscow, Russia
2 Central Clinical Hospital with polyclinic of Medical Center the Administrative, Department of the President of the Russian Federation, Moscow
3 Institute of Psychology named after L.S. Vygotsky, Federal State Budgetary Educational Institution of Higher Education Russian State University for the Humanities

Neuropsychiatric symptoms are one of the factors determining quality of life among Parkinson's disease patients, but often remain underestimated by clinicians, especially in early disease stage.

Objective: to study the clinical features of affective disorders and comorbid personality traits in prodrome of Parkinson's disease (PD) and their effect on treatment adherence.

Materials and methods: 29 patients with PD were studied with questionnaires (Toronto alexithymia scale (TAS); Minimult personal questionnaire; DSM-IV criteria (SCID-II); Hospital anxiety and depression scale (HADS); Hamilton Scale for the Assessment of Depression (HAM-D)), and clinical-psychopathological method with objective information collection, neurological examination and neuropsychological testing.

Results: Among the patients with PD, personality premorbid features cluster C were most prominent (48% patients). Affective disorders in the prodromal period of PD are dysthymia (13.7%); cyclothymia (6.8%); recurrent depressive disorder (34.4%); and single depressive episode (44.8%). Affective disorders in PD are characterized by late onset, the prevalence of anxiety, asthenic-apathetic symptoms, as well as a high level of alexithymia and somatization. We found the relationship of personality traits and adherence to therapy:  the least compliant are histrionic n = 3 (10.3%) and schizotypal n = 2 (6.9%) patients. A high prevalence of dissociative reactions (55%) was noted in response to a diagnosis of PD, which is similar to cancer patients.

Keywords: psychiatry, neurology, Parkinson's disease, psychoneurology

Published: January 1, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Samushiya MA, Ragimova AA, Smolentseva IG, M.Yu. M, Ivannikova EI. Affective and personality disorders in Parkinson's disease premotor phase. Pilot study. Cogn. Remediat. J. 2020;9(1):1-8. doi: 10.5507/crj.2020.001.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Schapira, A.H.V., Chaudhuri, K.R., Jenner P.(2017). Non-motor features of Parkinson disease. Nature Reviews Neuroscience, 18(8):509-509. <https://doi:10.1038/nrn.2017.91>. Go to original source...
    2. Rijk, M.C.D., Tzourio, C., Breteler, M.M., et al.(1997). Prevalence of parkinsonism and Parkinsons disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinsons disease. Journal of Neurology, Neurosurgery & Psychiatry, 62(1):10-15. <https://doi:10.1136/jnnp.62.1.10>. Go to original source...
    3. Klein, J., Rolinski, M., Griffanti, L., et al.(2018). Cortical structural involvement and cognitive dysfunction in early Parkinsons disease. NMR in Biomedicine, 31(4). <https://doi:10.1002/nbm.3900>. Go to original source...
    4. Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., Tredici, K.D.(2004). Stages in the development of Parkinson's disease-related pathology. Cell and Tissue Research, 318(1):121-134. <https://doi:10.1007/s00441-004-0956-9>. Go to original source...
    5. Khegai, О., Selyanina, N.(2018). Comparative characteristics of non-motor manifestations of Parkinson disease in men and women. Medical almanac. <https://doi:10.21145/2499-9954-2018-5-120-122>. Go to original source...
    6. Juri, C.C., Chaná, C.P.(2006). Levodopa for Parkinson's disease: What have we learned? Rev Med Chil, 134(7):893-901. Epub 2006 Aug 29. PMID 17130974 Go to original source...
    7. Chahine, L.M., Stern, M.B.(2014). Characterizing Premotor Parkinsons Disease: Clinical Features and Objective Markers. Movement Disorders Clinical Practice, 1(4):299-306. <https://doi:10.1002/mdc3.12062>. Go to original source...
    8. Chiu, P-Y., Tsai, C-T., Chen, P-K., Chen, W-J., Lai, T-J.(2016). Neuropsychiatric Symptoms in Parkinson's Disease Dementia Are More Similar to Alzheimer's Disease than Dementia with Lewy Bodies: A Case-Control Study. Plos One, 11(4). <https://doi:10.1371/journal.pone.0153989>. Go to original source...
    9. Lubomski, M., Rushworth, R.L., Tisch, S.(2014). Hospitalisation and comorbidities in Parkinsons disease: a large Australian retrospective study. Journal of Neurology, Neurosurgery & Psychiatry, 86(3):324-330. <https://doi:10.1136/jnnp-2014-307822>. Go to original source...
    10. Lin, H-L., Lin, H-C., Chen, Y-H.(2014). Psychiatric diseases predated the occurrence of Parkinson disease: a retrospective cohort study. Annals of Epidemiology, 24(3):206-213. <https://doi:10.1016/j.annepidem.2013.12.010>. Go to original source...
    11. Han, J.W., Ahn, Y.D., Kim, W-S., et al.(2018). Psychiatric Manifestation in Patients with Parkinsons Disease. Journal of Korean Medical Science, 33(47). <https://doi:10.3346/jkms.2018.33.e300>. Go to original source...
    12. Fuente-Fernández, R.D.L.(2013). Imaging of Dopamine in PD and Implications for Motor and Neuropsychiatric Manifestations of PD. Frontiers in Neurology, 4. <https://doi:10.3389/fneur.2013.00090>. Go to original source...
    13. Kim, S.R., Nho, J-H., Nam, J-H.(2017). Relationships among Type-D personality, symptoms and quality of life in patients with ovarian cancer receiving chemotherapy. Journal of Psychosomatic Obstetrics & Gynecology, 39(4):289-296. <https://doi:10.1080/0167482x.2017.1372416>. Go to original source...
    14. Poletti, M., Frosini, D., Pagni, C., et al.(2011). Alexithymia Is Associated with Depression in de novo Parkinson's Disease. Psychotherapy and Psychosomatics, 80(4):251-253. <https://doi:10.1159/000322029>. Go to original source...
    15. Sozinova, E.V.(2010). Parkinson's Patient Identity. Nervous Disease Treatment, 1(3): 29-33 (In Russ)
    16. Poewe W.(1990). The premorbid personality of patients with Parkinson's disease. New Vistas in Drug Research Early Markers in Parkinson's and Alzheimer's Diseases. 23-30. <https://doi:10.1007/978-3-7091-9098-2_4>. Go to original source...
    17. Lit, A.C.(1968). Man behind a mask. An analysis of the psychomotor phenomena of Parkinsons disease. ActaNeurol. Belg, 68:863-874. PMID 4976734
    18. Machover, S.(1957). Rorschach Study on the Nature and Origin of Common Factors in the Personalities of Parkinsonians. Psychosomatic Medicine, 19(4):332-338. <https://doi.org/10.1097/00006842-195707000-00010>. Go to original source...
    19. Prichard, J.S., Schwab, R.S., Tillmann, W.A.(1951). The Effects of Stress and the Results of Medication in Different Personalities with Parkinsonʼs Disease. Psychosomatic Medicine, 13(2):106-111. <https://doi.org/10.1097/00006842-195103000-00003>. Go to original source...
    20. Booth, G.(1948). Psychodynamics in Parkinsonism. Psychosomatic Medicine, 10(1):1-14. <https://doi.org/10.1097/00006842-194801000-00001>. Go to original source...
    21. Sands, I.J.(1942). The type of personality susceptible to Parkinson‟s
disease, J. Mt. Sinai Hosp, 9: 792-794.PMID 10911877
    22. Jelliflfe, S.E.(1940). The Parkinsonian Body Posture. The Journal of Nervous and Mental Disease, 91(5):663. <https://doi:10.1097/00005053-194005000-00030>. Go to original source...
    23. Sullivan, K.L., Mortimer, J.A., Wang, W., Zesiewicz, T.A., Brownlee, H., Borenstein, A.R.(2015). Occupational Characteristics and Patterns as Risk Factors for Parkinson's Disease: A Case Control Study. Journal of Parkinsons Disease, 5(4):813-820. <https://doi.org/10.3233/jpd-150635>. Go to original source...
    24. Rosen, J.B., Brand, M., Polzer, C., Ebersbach, G., Kalbe, E.(2013). Moral decision-making and theory of mind in patients with idiopathic Parkinson's disease. Neuropsychology, 27(5):562-572. <https://doi.org/10.1037/a0033595>. Go to original source...
    25. Gatto, N.M., Bordelon, Y., Gatz, M., Ritz, B.(2011). Personality Characteristics and Motor Skills Attributed to Occupations in Parkinson Disease. Cognitive and Behavioral Neurology, 24(1):18-25. <https://doi:10.1097/wnn.0b013e318218c5eb>. Go to original source...
    26. Abe, N., Fujii, T., Hirayama, K., et al.(2009). Do parkinsonian patients have trouble telling lies? The neurobiological basis of deceptive behaviour. Brain, 132(5):1386-1395.<https://doi.org/10.1093/brain/awp052>. Go to original source...
    27. Schneider, J.S.(2007). Behavioral persistence deficit in Parkinsons disease patients. European Journal of Neurology, 14(3):300-304. <https://doi.org/10.1111/j.1468-1331.2006.01647.xм>. Go to original source...
    28. Hooker, C., Roese, N.J., Park, S.(2000). Impoverished Counterfactual Thinking is Associated with Schizophrenia. Psychiatry, 63(4):326-335. <https://doi.org/10.1080/00332747.2000.11024925>. Go to original source...
    29. Ward, C.D., Duvoisin, R.C., Ince, S.E., Nutt, J.D., Eldridge, R., Calne, D.B.(1983). Parkinsons disease in 65 pairs of twins and in a set of quadruplets. Neurology, 33(7):815-815. <https://doi.org/10.1212/wnl.33.7.815>. Go to original source...
    30. Menza, M.A., Robertson-Hoffman, D.E., Bonapace, A.S.(1993). Parkinsons disease and anxiety: Comorbidity with depression. Biological Psychiatry, 34(7):465-470. <https://doi:10.1016/0006-3223(93)90237-8>. Go to original source...
    31. Duvoisin, R.C., Eldridge, R., Williams, A., Nutt, J., Calne, D.(1981). Twin study of Parkinson disease. Neurology, 31(1):77-77. <https://doi.org/10.1212/wnl.31.1.77>. Go to original source...
    32. Cerasa A.(2018). Re-examining the Parkinsonian Personality hypothesis: A systematic review. Personality and Individual Differences, 130:41-50. <https://doi:10.1016/j.paid.2018.03.045>. Go to original source...
    33. Baig, F., Lawton, M.A., Rolinski, M., et al.(2017). Personality and addictive behaviours in early Parkinsons disease and REM sleep behaviour disorder. Parkinsonism & Related Disorders, 37:72-78. <https://doi:10.1016/j.parkreldis.2017.01.017>. Go to original source...
    34. Volpato, C., Signorini, M., Meneghello, F., Semenza, C.(2009). Cognitive and Personality Features in Parkinson Disease: 2 Sides of the Same Coin? Cognitive and Behavioral Neurology, 22(4):258-263. <https://doi:10.1097/wnn.0b013e3181c12c63>. Go to original source...
    35. Luca, A., Nicoletti, A., Mostile, G., Zappia, M.(2019). The Parkinsonian Personality: More Than Just a "Trait." Frontiers in Neurology, 9. <https://doi:10.3389/fneur.2018.01191>. Go to original source...
    36. Nicoletti, A., Luca, A., Raciti, L., et al.(2013). Obsessive Compulsive Personality Disorder and Parkinson's Disease. PLoS ONE, 8(1). <https://doi:10.1371/journal.pone.0054822>. Go to original source...
    37. Fineberg, N.A., Potenza, M.N., Chamberlain, S.R., et al.(2009). Probing Compulsive and Impulsive Behaviors, from Animal Models to Endophenotypes: A Narrative Review. Neuropsychopharmacology, 35(3):591-604. <https://doi:10.1038/npp.2009.185>. Go to original source...
    38. Stallings, M.C., Hewitt, J.K., Cloninger, C.R., Heath, A.C., Eaves, L.J.(1996). Genetic and environmental structure of the Tridimensional Personality Questionnaire: Three or four temperament dimensions? Journal of Personality and Social Psychology, 70(1):127-140. <https://doi:10.1037/0022-3514.70.1.127>. Go to original source...
    39. Heinz, A.(2017). A New Understanding of Mental Disorders: Computational Models for Dimensional Psychiatry. Cambridge, MA: MIT press. Go to original source...
    40. Wunderink, L., Nieboer, R.M., Wiersma, D., Sytema, S., Nienhuis, F.J.(2013). Recovery in Remitted First-Episode Psychosis at 7 Years of Follow-up of an Early Dose Reduction/Discontinuation or Maintenance Treatment Strategy. JAMA Psychiatry, 70(9):913. <https://doi:10.1001/jamapsychiatry.2013.19>. Go to original source...
    41. Deserno, L., Huys, Q.J.M., Boehme, R., et al.(2015). Ventral striatal dopamine reflects behavioral and neural signatures of model-based control during sequential decision making. Proceedings of the National Academy of Sciences, 112(5):1595-1600. <https://doi:10.1073/pnas.1417219112>. Go to original source...
    42. Costa, A., Peppe, A., Carlesimo, G.A., Pasqualetti, P., Caltagirone, C.(2006). Alexithymia in Parkinsons disease is related to severity of depressive symptoms. European Journal of Neurology, 13(8):836-841. <https://doi:10.1111/j.1468-1331.2006.01216.x>. Go to original source...
    43. Sharp, M.E., Foerde, K., Daw, N.D., Shohamy, D.(2015). Dopamine selectively remediates 'model-based' reward learning: a computational approach. Brain, 139(2):355-364. <https://doi:10.1093/brain/awv347>. Go to original source...
    44. Sieurin, J., Gustavsson, P., Weibull, C.E., et al.(2015). Personality traits and the risk for Parkinson disease: a prospective study. European Journal of Epidemiology, 31(2):169-175. <https://doi:10.1007/s10654-015-0062-1>. Go to original source...
    45. Lahey, B.B. (2009). Public health significance of neuroticism. American Psychologist, 64(4):241-256. <https://doi.org/10.1037/a0015309>. Go to original source...
    46. Bell, I.R., Amend, D., Kaszniak, A.W., et al.(1995). Trait shyness in the elderly: evidence for an association with Parkinson's disease in family members and biochemical correlates. J Geriatr Psychiatry Neurol, 8:16-22 PMID: 7710641
    47. Chen, J.J., Marsh L.(2013). Anxiety in Parkinson's disease: identification and management. Therapeutic Advances in Neurological Disorders, 7(1):52-59. <https://doi:10.1177/1756285613495723>. Go to original source...
    48. Weisskopf, M.G., Chen, H., Schwarzschild, M.A., Kawachi, I., Ascherio, A.(2003). Prospective study of phobic anxiety and risk of Parkinsons disease. Movement Disorders, 18(6):646-651. <https://doi:10.1002/mds.10425>. Go to original source...
    49. Valli, M., Mihaescu, A., Strafella, A.P.(2017). Imaging behavioural complications of Parkinson's disease. Brain Imaging and Behavior, 13(2):323-332. <https://doi.org/10.1007/s11682-017-9764-1>. Go to original source...
    50. Broen, M.P.G., Narayen, N.E., Kuijf, M.L., Dissanayaka, N.N.W., Leentjens, A.F.G.(2016). Prevalence of anxiety in Parkinsons disease: A systematic review and meta-analysis. Movement Disorders, 31(8):1125-1133. <https://doi.org/10.1002/mds.26643>. Go to original source...
    51. Remy ,P., Doder, M., Lees, A., Turjanski, N., Brooks, D.(2005). Depression in Parkinsons disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain, 128(6):1314-1322. <https://doi:10.1093/brain/awh445>. Go to original source...
    52. Wiesli, D., Meyer, A., Fuhr, P., Gschwandtner, U.(2017). Influence of Mild Cognitive Impairment, Depression, and Anxiety on the Quality of Life of Patients with Parkinson Disease. Dementia and Geriatric Cognitive Disorders Extra, 7(3):297-308. <https://doi.org/10.1159/000478849>. Go to original source...
    53. Siciliano, M., Trojano, L., Micco, R.D., et al.(2017). Motor, behavioural, and cognitive correlates of fatigue in early, de novo Parkinson disease patients. Parkinsonism & Related Disorders, 45:63-68. <https://doi.org/10.1016/j.parkreldis.2017.10.004>. Go to original source...
    54. Carrozzino, D., Morberg, B.M., Siri, C., Pezzoli, G., Bech, P.(2018). Evaluating psychiatric symptoms in Parkinsons Disease by a clinimetric analysis of the Hopkins Symptom Checklist (SCL-90-R). Progress in Neuro-Psychopharmacology and Biological Psychiatry, 81:131-137. <https://doi.org/10.1016/j.pnpbp.2017.10.024>. Go to original source...
    55. Timpka, J., Svensson, J., Nilsson, M.H., Pålhagen, S., Hagell, P., Odin, P.(2016). Workforce unavailability in Parkinsons disease. Acta Neurologica Scandinavica, 135(3):332-338. <https://doi.org/10.1111/ane.12602>. Go to original source...
    56. Dissanayaka, N.N.N.W., White, E., O'Sullivan, J.D., Marsh, R., Pachana, N.A., Byrne, G.J.(2014). The clinical spectrum of anxiety in Parkinson's disease. Movement Disorders. 17. <https://doi: 10.1002/nbm.3900>. Go to original source...
    57. Dissanayaka, N.N.W., Osullivan, J.D., Pachana, N.A., et al.(2016). Disease-specific anxiety symptomatology in Parkinsons disease. International Psychogeriatrics, 28(7):1153-1163. <https://doi:10.1017/s1041610215002410>. Go to original source...
    58. Ozdilek, F.B., Bestepe, E.E., Gultekin, B.K.(2014). Social phobia in Parkinson's disease: Prevalence and risk factors. Neuropsychiatric Disease and Treatment, 829. <https://doi.org/10.2147/ndt.s62942>. Go to original source...
    59. Behari, M., Srivastava, A.K., Das, R.R., Pandey, R.(2001). Risk factors of Parkinsons disease in Indian patients. Journal of the Neurological Sciences, 190(1-2):49-55. <https://doi:10.1016/s0022-510x(01)00578-0>. Go to original source...
    60. Leentjens, A.F., Akker, M.V.D., Metsemakers, J.F., Lousberg, R., Verhey, F.R.(2003). Higher incidence of depression preceding the onset of Parkinsons disease: A register study. Movement Disorders, 18(4):414-418. <https://doi:10.1002/mds.10387>. Go to original source...
    61. Schuurman, A.G., Akker, M.V.D., Ensinck, K.T., et al.(2002). Increased risk of Parkinsons disease after depression: A retrospective cohort study. Neurology, 58(10):1501-1504. <https://doi:10.1212/wnl.58.10.1501>. Go to original source...
    62. Novaretti, T.M., Novaretti, N., Tumas, V.(2016). Bipolar disorder, a precursor of Parkinsons disease? Dementia & Neuropsychologia, 10(4):361-364. <https://doi:10.1590/s1980-5764-2016dn1004018>. Go to original source...
    63. Kummer, A., Dias, F.M.V., Cardoso, F., Teixeira, A.L.(2010). Low frequency of bipolar disorder, dopamine dysregulation syndrome, and punding in Brazilian patients with Parkinsons disease. Revista Brasileira de Psiquiatria, 32(1):62-65. <https://doi:10.1590/s1516-44462010000100012>. Go to original source...
    64. Weintraub, D., David, A.S., Evans, A.H., Grant, J.E., Stacy, M.(2014). Clinical spectrum of impulse control disorders in Parkinsons disease. Movement Disorders, 30(2):121-127. <https://doi:10.1002/mds.26016>. Go to original source...
    65. Andlin-Sobocki, P., Rossler, W.(2005). Cost of psychotic disorders in Europe. European Journal of Neurology, 12:74-77. <https://doi:10.1111/j.1468-1331.2005.01198.x>. Go to original source...
    66. Winograd-Gurvich, C., Fitzgerald, P., Georgiou-Karistianis, N., Bradshaw, J., White O.(2006). Negative symptoms: A review of schizophrenia, melancholic depression and Parkinsons disease. Brain Research Bulletin, 70(4-6):312-321. <https://doi:10.1016/j.brainresbull.2006.06.007>. Go to original source...
    67. Pläschke, R.N., Cieslik, E.C., Müller, V.I., et al.(2017). On the integrity of functional brain networks in schizophrenia, Parkinsons disease, and advanced age: Evidence from connectivity-based single-subject classification. Human Brain Mapping, 38(12):5845-5858. <https://doi:10.1002/hbm.23763>. Go to original source...
    68. Smulevich A. B., Ivanov S. V., Myasnikova L. K., Dvojnikov S. YU., Samushiya M. A., Petelin D. S.(2014). Dissociative disorders in oncology: psychopathology, aspects of comorbidity with personality disorders. Mental disorders in general medicine, 3-4:4-14 (In Russ).
    69. Ivanov S. V., Petelin D. S.(2016). Typology of nosogenic reactions with the phenomena of autoaggression (procrastination phenomenon) in malignant neoplasms. Mental disorders in general medicine, 3:17-25 (In Russ). Go to original source...

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content